Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
GIP (Glucose-Dependent Insulinotropic Polypeptide): Acts synergistically with GLP-1
Given the fact that fast-food restaurants are still the most popular type of restaurant among GLP-1 users, this surge in fruit and vegetable intake is worth noting
Want to start your journey
117 Beinaglutide Beinaglutide was the first original drug approved for the treatment of obesity in China and the third GLP-1 class reduction drug approved worldwide, and it represents a new treatment option for overweight and obese patients
Most protocols start at a low dose and increase at regular intervals (typically every 4 weeks)
US$ 27.01
US$ 29.15
US$ 28.32
US$ 26.71
US$ 23.04
US$ 26.30
US$ 21.65
US$ 20.47
US$ 27.05
US$ 29.70
US$ 26.55
